Trexquant Investment’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,470
| Closed | -$46K | – | 1625 |
|
|
2023
Q1 | $46K | Sell |
1,470
-881
| -37% | -$27.6K | ﹤0.01% | 1393 |
|
|
2022
Q4 | $165K | Sell |
2,351
-4,322
| -65% | -$304K | ﹤0.01% | 1273 |
|
|
2022
Q3 | $575K | Sell |
6,673
-3,146
| -32% | -$271K | 0.02% | 754 |
|
|
2022
Q2 | $812K | Buy |
9,819
+6,233
| +174% | +$515K | 0.04% | 610 |
|
|
2022
Q1 | $596K | Buy |
3,586
+1,408
| +65% | +$234K | 0.03% | 689 |
|
|
2021
Q4 | $364K | Buy |
2,178
+564
| +35% | +$94.3K | 0.02% | 810 |
|
|
2021
Q3 | $139K | Buy |
1,614
+195
| +14% | +$16.8K | 0.01% | 1018 |
|
|
2021
Q2 | $77K | Buy |
+1,419
| New | +$77K | 0.01% | 1032 |
|
|
2020
Q3 | – | Sell |
-5,130
| Closed | -$266K | – | 1390 |
|
|
2020
Q2 | $266K | Buy |
+5,130
| New | +$266K | 0.02% | 938 |
|